Pro-tPA for the treatment of thrombosis, embolism and related conditions
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Dec 14, 1999
Issued Date -
N/A
app pub date -
May 26, 1992
filing date -
Dec 14, 1982
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
Pro-tPA has a higher affinity for fibrin and better selectivity than tPA and is used for the management and prophylaxis of thrombosis, embolism, and related conditions. A pharmaceutical composition comprises a physiological compatible medium and pro-tPA employed in a couple of 70-100% pro-tPA and 0-30% of tPA.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully